Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.
Location: Australia, New South Wales, Sydney
Member count: 1-10
Total raised: $5M
Investors 2
| Date | Name | Website |
| - | Empath Ven... | empath.vc |
| 15.11.2022 | Main Seque... | mseq.vc/ |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 27.10.2022 | Seed | $5M | - | - |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 27.10.2022 | Six Aussie... | It’s been a huge week for Aust... | - | - | smartcompa... |